ÐÓ°ÉÔ­´´

Tissium, based in Paris, shows significant growth potential in the healthcare sector with its innovative biodegradable sealants and adhesives for wound closure. Unlike traditional methods such as sutures, staples, and non-biodegradable adhesives, Tissium’s products promote faster healing, fewer complications, and less invasive procedures. This approach addresses a critical need by potentially eliminating removal procedures and lowering associated risks. Supported by investors like Bpifrance and Sofinnova Partners, Tissium is well-positioned to disrupt the market with its B2B model, offering a compelling alternative to current wound care technologies.